Gerri Anselmo-Gallagher

About Gerri Anselmo-Gallagher

For more than 20 years, I’ve led clinical operations and site strategy across academia, CRO, and global biopharma—building scalable models that accelerate U.S. trial start-up and strengthen portfolio delivery across multiple therapeutic areas.At GSK, I lead U.S. Site Strategy & Engagement across Oncology, Vaccines, Infectious Disease/HIV, Specialty, and Respiratory portfolios. My team drives territory development, new-to-research and new-to-GSK expansion, and just-in-time activation aligned to feasibility signals and portfolio demand—focused on measurable performance and start-up acceleration.Earlier, I directed large-scale clinical operations organizations with accountability for start-up KPIs, activation timelines, vendor governance, and regulatory compliance across the Americas.What guides my leadership:• Operational clarity accelerates feasibility and activation• Territory development strengthens portfolio resilience• Innovation should reduce friction—not add process• Governance must enable performance• Partnerships must align to delivery outcomesSite strategy is not a support function—it is a core driver of clinical execution.

Experience

1. Head Us Site Srategy & Engagement

   GSK

   Oct 2022 — Present

Education

• Penn State University

  B.S., Counseling and Rehabilitation

• The George Washington University School of Medicine and Health Sciences

  M.S.H.S., Clinical Research Administration

Skills

• Infectious Diseases
• Clinical Development
• CRO Management
• Life Sciences
• Good Clinical Practice (Gcp)
• Biotechnology
• Ich-Gcp
• Regulatory Affairs
• Lifesciences
• Orthopedic
• Cardiology
• Clinical Trials
• Clinical Operations
• Pharmaceutical Industry
• Sop
• Clinical Monitoring
• Medical Writing
• Diabetes
• Gastroenterology
• Line Management
• Oncology
• Edc
• Clinical Data Management
• Therapeutic Areas
• Ctms
• Medical Devices
• Clinical Research
• Gcp
• CRO